Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02053831 · ClinicalTrials.gov registry record

GalaFlex Mesh in Facelift

A clinical trial of Superficial Musculoaponeurotic System (SMAS) Procedure, sponsored by C. R. Bard.

Completed
Registry status
15
Enrollment target
3
Study locations

NCT02053831: Completed study of Superficial Musculoaponeurotic System (SMAS) Procedure, sponsored by C. R. Bard.

NCT02053831 is a study of Superficial Musculoaponeurotic System (SMAS) Procedure that has completed, run by C. R. Bard. The registered enrollment target is 15 participants. The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02053831, a study of Superficial Musculoaponeurotic System (SMAS) Procedure, has completed, sponsored by C. R. Bard.

COMPLETED
Registry status
15 participants
Enrollment target
3
Study locations

Study Summary

In this post market study a resorbable mesh (GalaFLEX) will be used to reinforce the lifted and imbricated SMAS along the suture lines and spread the load of the SMAS along a greater surface area. GalaFLEX mesh is comprised of resorbable 4-hydroxybutyrate fibers.

Primary Outcome

Investigator satisfaction will be judged by ease of product use, successful reinforcement, and total time for procedure to be completed.

Study Locations (3)

Illinois

  • The Few Institute for Aesthetic Plastic Surgery - Chicago
  • Eye and Ear Institute - Chicago

Florida

  • Ponte Vedra Plastic Surgery - Ponte Vedra Beach

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-11
Est. Completion 2014-06
C. R. Bard

75 total trials

What the finished NCT02053831 record still lists

NCT02053831 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.

The record links to 1 condition, with Superficial Musculoaponeurotic System (SMAS) Procedure appearing as the primary indexed condition, and to 0 interventions.

NCT02053831 reports a single indexed study location in Illinois, Florida.

Frequently Asked Questions

What is clinical trial NCT02053831 about?

NCT02053831 is a clinical study titled "GalaFlex Mesh in Facelift". In this post market study a resorbable mesh (GalaFLEX) will be used to reinforce the lifted and imbricated SMAS along the suture lines and spread the load of the SMAS along a greater surface area. GalaFLEX mesh is comprised of resorbable 4-hydroxybutyrate fibers.

What is the current status of trial NCT02053831?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2011-11. Estimated completion is 2014-06.

What conditions does trial NCT02053831 study?

This clinical trial studies the following conditions: Superficial Musculoaponeurotic System (SMAS) Procedure.

Who is sponsoring clinical trial NCT02053831?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02053831 being conducted?

This trial has 3 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02053831, the US trial registry maintained by the National Library of Medicine. NCT02053831 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.